ADUS insider sale: President/COO sold 4,000 shares at $115.75

Addus HomeCare Corp. (ADUS) insider filing shows W. Bradley Bickham, the company's President and COO, reported a sale of 4,000 shares of common stock on 09/02/2025 at a weighted-average price of $115.75.

Rhea-AI Filing Summary

Addus HomeCare Corp. (ADUS) insider filing shows W. Bradley Bickham, the company's President and COO, reported a sale of 4,000 shares of common stock on 09/02/2025 at a weighted-average price of $115.75. After the sale he beneficially owned 37,605 shares. The Form 4 was filed as a single-person report and was signed by an attorney-in-fact for Mr. Bickham on 09/03/2025. The filing discloses the sale prices ranged from $115.48 to $116.14.

Insights

Securities Analyst

TL;DR: Insider sale of 4,000 shares by the President and COO is disclosed; transaction size appears routine relative to total holdings.

The Form 4 indicates an executed sale on 09/02/2025 of 4,000 common shares at a weighted-average price of $115.75, leaving the reporting person with 37,605 shares. The disclosure includes a price range ($115.48–$116.14) and an offer to provide detailed per-price quantities on request. As a securities analyst, I view this as a transparent disclosure of liquidity by an officer rather than evidence of a corporate development; the filing does not state any plan-based (10b5-1) designation or provide reasons for the sale.

Corporate Governance Expert

TL;DR: Proper Form 4 reporting and attorney-in-fact signature demonstrate compliance with disclosure obligations.

The filing properly identifies the reporting person, relationship to the issuer (President and COO), transaction date, quantities, weighted-average price, remaining beneficial ownership, and contains the required signature block executed by an attorney-in-fact. The inclusion of a note offering detailed execution-price breakdowns supports transparency. No governance issues, restrictions, or exemptions are stated within the filing.

Insider Trade Summary

Net Seller: 4,000 shares

Net Sell 1 txn

Insider BICKHAM W BRADLEY

Role President and COO

Sold 4,000 shs ($463K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,000	$115.75	$463K

Holdings After Transaction: Common Stock — 37,605 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.48 to $116.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

FAQ

What shares did ADUS insider W. Bradley Bickham sell on 09/02/2025?

The filing reports a sale of 4,000 shares of ADUS common stock on 09/02/2025.

At what price were the ADUS shares sold by the insider?

The weighted-average sale price was $115.75, with individual transactions ranging from $115.48 to $116.14.

How many ADUS shares does W. Bradley Bickham own after the reported sale?

After the reported transaction, he beneficially owned 37,605 shares.

What is W. Bradley Bickham's role at Addus HomeCare (ADUS)?

The Form 4 lists his relationship to the issuer as President and COO.

Who signed the Form 4 for the reporting person?

The form was signed by Brian Poff, Attorney-in-Fact for W. Bradley Bickham on 09/03/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BICKHAM W BRADLEY

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		S		4,000	D	$115.75(1)	37,605	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.48 to $116.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

	/s/ Brian Poff, Attorney-in-Fact for W. Bradley Bickham	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.